The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups
Abstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTMedicinal Chemistry of hERG Optimizations: Highlights and Hang-UpsCraig Jamieson, Elizabeth M. Moir, Zoran Rankovic, and Grant WishartView Author Information Medicinal Chemistry, Organon Laboratories Ltd., Newhouse, Lanarkshire ML1 5SH, Scotland, U.K. Cite this: J. Med. Chem. 2006, 49, 17, 5029–5046Publication Date (Web):July 27, 2006Publication History Received31 March 2006Published online27 July 2006Published inissue 1 August 2006https://pubs.acs.org/doi/10.1021/jm060379lhttps://doi.org/10.1021/jm060379lreview-articleACS PublicationsCopyright © 2006 American Chemical SocietyRequest reuse permissionsArticle Views10346Altmetric-Citations366LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Modification,Optimization,Partition coefficient,Redox reactions,Selectivity Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,354
Molecular and Cellular Mechanisms of Cardiac Arrhythmias
Keating, M. T., & Sanguinetti, M. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00243-4 · Cited by 1,001
Voltage Sensor of Kv1.2: Structural Basis of Electromechanical Coupling
Long, S. B., Campbell, E. B., & MacKinnon, R. (2005) · Science · doi:10.1126/science.1116270 · Cited by 979
A structural basis for drug-induced long QT syndrome
Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210244497 · Cited by 944
The impact of drug-induced QT interval prolongation on drug discovery and development
Fermini, B., & Fossa, A. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1108 · Cited by 492
Predicting drug–hERG channel interactions that cause acquired long QT syndrome
Sanguinetti, M. C., & Mitcheson, J. S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.003 · Cited by 300
Recanatini, M., Poluzzi, E., Masetti, M., Cavalli, A., & De Ponti, F. (2005) · Medicinal Research Reviews · doi:10.1002/med.20019 · Cited by 285
Predictive in silico modeling for hERG channel blockers
Aronov, A. M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03278-7 · Cited by 267
Ekins, S., Crumb, W. J., Sarazan, R. D., Wikel, J. H., & Wrighton, S. A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.427 · Cited by 260
Pentamidine-Induced Long QT Syndrome and Block of hERG Trafficking
Kuryshev, Y. A., Ficker, E., Wang, L., Hawryluk, P., Dennis, A. T., Wible, B. A., Brown, A. M., Kang, J., Chen, X.-L., Sawamura, K., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073692 · Cited by 258
Cardiac Actions of Antihistamines
Woosley, R. L. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001313 · Cited by 256
Pearlstein, R. A., Vaz, R. J., Kang, J., Chen, X.-L., Preobrazhenskaya, M., Shchekotikhin, A. E., Korolev, A. M., Lysenkova, L. N., Miroshnikova, O. V., Hendrix, J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00196-3 · Cited by 222
Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block
Sánchez-Chapula, J. A., Navarro-Polanco, R. A., Culberson, C., Chen, J., & Sanguinetti, M. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200448200 · Cited by 172
Pearlstein, R., Vaz, R., & Rampe, D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205651 · Cited by 163
Gintant, G. A., Limberis, J. T., McDermott, J. S., Wegner, C. D., & Cox, B. F. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200105000-00012 · Cited by 158
Greater Than the Sum of Its Parts: Combining Models for Useful ADMET Prediction
O’Brien, S., & de Groot, M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049254b · Cited by 116
Development and Evaluation of an in Silico Model for hERG Binding
Song, M., & Clark, M. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050308f · Cited by 103
Predictive models for hERG potassium channel blockers
Cianchetta, G., Li, Y., Kang, J., Rampe, D., Fravolini, A., Cruciani, G., & Vaz, R. J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.062 · Cited by 86
In vitroandin vivomodels for testing arrhythmogenesis in drugs
Carlsson, L. G. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01590.x · Cited by 62
Bilodeau, M. T., Balitza, A. E., Koester, T. J., Manley, P. J., Rodman, L. D., Buser‐Doepner, C., Coll, K. E., Fernandes, C., Gibbs, W. W., Heimbrook, D. C., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049697f · Cited by 61
McCauley, J. A., Theberge, C. R., Romano, J. J., Billings, S. B., Anderson, K. D., Claremon, D. A., Freidinger, R. M., Bednar, R. A., Mosser, S. D., Gaul, S. L., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030483s · Cited by 57
Edmondson, S. D., Mastracchio, A., Duffy, J. L., Eiermann, G. J., He, H., Ita, I. E., Leiting, B., Leone, J. F., Lyons, K. A., Makarewicz, A., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.028 · Cited by 48
Effects of H1 Antihistamines on Animal Models of QTc Prolongation
Gras, J., & Llenas, J. (1999) · Drug Safety · doi:10.2165/00002018-199921001-00006 · Cited by 25
The 18th European Symposium on Quantitative Structure–Activity Relationships
Tsantili‐Kakoulidou, A., & Agrafiotis, D. K. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.560604 · Cited by 14
Cited by
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Zhou, Y., Wang, J., Gu, Z., Wang, S., Zhu, W., Aceña, J. L., Soloshonok, V. A., Izawa, K., & Liu, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00392 · Cited by 2,808
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
The influence of lipophilicity in drug discovery and design
Arnott, J. A., & Planey, S. L. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.714363 · Cited by 868
Metadata
- Authors
- Jamieson, C., Moir, E. M., Rankovic, Z., & Wishart, G.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-07-27
- Volume
- 49
- Issue
- 17
- Pages
- 5029-5046
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2018285323
- Cited by
- 423
- References
- 24
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.